Literature DB >> 35220492

Mitochondrial Sirtuins in Parkinson's Disease.

Ling He1,2, Jihong Wang3, Yazhi Yang4, Jian Li5, Huaijun Tu6.   

Abstract

Parkinson's disease (PD), the main risk factor for which is age, is one of the most common neurodegenerative diseases and imposes a substantial burden on affected individuals and the economy. While the aetiology of PD is still largely unclear, substantial evidence indicates that mitochondrial dysfunction, aggregation of α-synuclein (α-syn), oxidative stress, inflammation, and autophagy play major roles in the pathogenesis of PD. Sirtuins are NAD+-dependent protein deacetylases, includeing seven members, i.e., SIRT1-SIRT7. Among these sirtuins, SIRT3, SIRT4 and SIRT5 are located in mitochondria and are called mitochondrial sirtuins. Mitochondrial sirtuins regulate the activity and biological function of mitochondrial proteins through posttranslational modification of substrate proteins. Increasing evidence shows that mitochondrial sirtuins play an important role in degenerative diseases, including PD. Mitochondrial sirtuins exert a beneficial neuroprotective effect in various models of PD. This paper summarizes a large number of studies and discusses the latest research progress on the role of mitochondrial sirtuins in PD, focusing especially on the regulation of the mitochondrial respiratory chain (MRC), oxidative stress, the inflammatory response and autophagy, to provide new insight into the pathogenesis of PD and new targets for the diagnosis and treatment of the disease.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autophagy; Inflammation; Mitochondrial respiratory chain; Mitochondrial sirtuins; PD; ROS

Mesh:

Substances:

Year:  2022        PMID: 35220492     DOI: 10.1007/s11064-022-03560-w

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  104 in total

Review 1.  NAD+ metabolism and its roles in cellular processes during ageing.

Authors:  Anthony J Covarrubias; Rosalba Perrone; Alessia Grozio; Eric Verdin
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

Review 2.  The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications.

Authors:  Chris Carrico; Jesse G Meyer; Wenjuan He; Brad W Gibson; Eric Verdin
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

Review 3.  NAD+ in Brain Aging and Neurodegenerative Disorders.

Authors:  Sofie Lautrup; David A Sinclair; Mark P Mattson; Evandro F Fang
Journal:  Cell Metab       Date:  2019-10-01       Impact factor: 27.287

4.  Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.

Authors:  Lei Liu; Carina Peritore; Jessica Ginsberg; Jennifer Shih; Siddharth Arun; Gizem Donmez
Journal:  Behav Brain Res       Date:  2014-12-23       Impact factor: 3.332

Review 5.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

Review 6.  Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.

Authors:  Xavier Palomer; David Aguilar-Recarte; Raquel García; J Francisco Nistal; Manuel Vázquez-Carrera
Journal:  Trends Mol Med       Date:  2021-04-07       Impact factor: 11.951

Review 7.  Sirtuin deacetylases in neurodegenerative diseases of aging.

Authors:  Adrianna Z Herskovits; Leonard Guarente
Journal:  Cell Res       Date:  2013-05-21       Impact factor: 25.617

Review 8.  Progress towards therapies for disease modification in Parkinson's disease.

Authors:  Nirosen Vijiaratnam; Tanya Simuni; Oliver Bandmann; Huw R Morris; Thomas Foltynie
Journal:  Lancet Neurol       Date:  2021-07       Impact factor: 59.935

9.  SIRT3 Protects Rotenone-induced Injury in SH-SY5Y Cells by Promoting Autophagy through the LKB1-AMPK-mTOR Pathway.

Authors:  Meng Zhang; Yong-Ning Deng; Jing-Yi Zhang; Jie Liu; Yan-Bo Li; Hua Su; Qiu-Min Qu
Journal:  Aging Dis       Date:  2018-04-01       Impact factor: 6.745

10.  Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Neural Regen Res       Date:  2020-11       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.